The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study

[1]  C. Caballero-Uribe,et al.  Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys. , 2023, Rheumatology.

[2]  S. Santhanam,et al.  Covid‐19 vaccination in autoimmune rheumatic diseases: A multi‐center survey from southern India , 2022, International journal of rheumatic diseases.

[3]  S. Tharwat,et al.  Rheumatologists’ knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey , 2022, Rheumatology International.

[4]  I. Peláez-Ballestas,et al.  Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study , 2022, Human vaccines & immunotherapeutics.

[5]  A. Iagnocco,et al.  EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update , 2022, Annals of the Rheumatic Diseases.

[6]  J. Bijlsma.  EULAR 2021 updated viewpoints on SARS-CoV-2 vaccination in patients with RMDs: a guidance to answer patients’ questions , 2022, Annals of the Rheumatic Diseases.

[7]  I. Peláez-Ballestas,et al.  COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases , 2021, Human vaccines & immunotherapeutics.

[8]  X. Mariette,et al.  Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry , 2021, Annals of the Rheumatic Diseases.

[9]  D. Solomon,et al.  Acceptability of Vaccines Against Preventable Infections Including Coronavirus Disease 2019 Among Patients With Rheumatic Disease , 2021, ACR open rheumatology.

[10]  C. Alpuche-Aranda,et al.  Acceptance, refusal and hesitancy of Covid-19 vaccination in Mexico: Ensanut 2020 Covid-19. , 2021, Salud publica de Mexico.

[11]  L. Arnaud,et al.  Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries , 2021, The Lancet Rheumatology.

[12]  E. Morand,et al.  SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study , 2021, Human vaccines & immunotherapeutics.

[13]  D. El-Hammady,et al.  Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt , 2021, Rheumatology International.

[14]  P. Gaur,et al.  COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey , 2021, Rheumatology International.

[15]  B. Poyraz,et al.  Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey , 2021, Rheumatology International.

[16]  R. Scrivo,et al.  SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists , 2021, Annals of the Rheumatic Diseases.

[17]  J. Gottenberg,et al.  Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases , 2021, The Lancet Rheumatology.

[18]  R. Mu,et al.  Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data , 2021, Autoimmunity Reviews.

[19]  L. Trupin,et al.  Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry , 2021, Annals of the Rheumatic Diseases.

[20]  S. Seneviratne,et al.  COVID-19 vaccine landscape , 2020, Journal of the Ceylon College of Physicians.

[21]  S. Lewandowsky,et al.  COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II , 2020, Psychological Medicine.

[22]  Lawrence O Gostin,et al.  A global survey of potential acceptance of a COVID-19 vaccine , 2020, Nature Medicine.

[23]  J. Singh,et al.  Management of Rheumatic Diseases During the COVID‐19 Pandemic: A National Veterans Affairs Survey of Rheumatologists , 2020, Arthritis care & research.

[24]  M. L. Di Pietro,et al.  The vaccine against COVID-19 and institutional trust. , 2020, Enfermedades infecciosas y microbiologia clinica.

[25]  N. MacDonald.  Vaccine hesitancy: Definition, scope and determinants. , 2015, Vaccine.

[26]  M. Cardiel,et al.  Actualización de la Guía Mexicana para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología , 2014 .

[27]  Naomi B. Robbins,et al.  Design of Diverging Stacked Bar Charts for Likert Scales and Other Applications , 2014 .

[28]  J. Santos.  «La vacunación en México en el marco de las "décadas de las vacunas": logros y desafíos» , 2014 .

[29]  H. Morgenstern,et al.  Ecologic studies in epidemiology: concepts, principles, and methods. , 1995, Annual review of public health.

[30]  M. Cardiel,et al.  Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis. , 2014, Reumatologia clinica.